<!doctype html><html lang=en-us><head><meta name=generator content="Hugo 0.136.2"><meta charset=utf-8><meta http-equiv=X-UA-Compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1"><title>OpenADMET </title><meta name=description content="Next generation ADMET modelling for therapeutic development"><meta name=author content="OpenADMET"><meta property="og:url" content="https://openadmet.org/"><meta property="og:site_name" content="OpenADMET"><meta property="og:title" content="OpenADMET Consortium"><meta property="og:description" content="Next generation ADMET modelling for therapeutic development"><meta property="og:locale" content="en_us"><meta property="og:type" content="website"><link href=/index.xml rel=alternate type=application/rss+xml title=OpenADMET><link rel=canonical href=https://openadmet.org/><link rel=openadmet-icon href=/images/icon.png><link href=/css/font.css rel=stylesheet type=text/css><link href=/css/kube.min.css rel=stylesheet type=text/css><link href=/css/kube.legenda.css rel=stylesheet type=text/css><link href=/css/highlight.css rel=stylesheet type=text/css><link href=/css/main.css rel=stylesheet type=text/css><link href=/css/custom.css rel=stylesheet type=text/css><script src=/js/jquery-2.1.4.min.js type=text/javascript></script><script type=text/javascript src=/js/tocbot.min.js></script></head><body class=page-kube><header><div class=show-sm><div id=nav-toggle-box><div id=nav-toggle-brand><a href=/>OpenADMET</a></div><a data-component=toggleme data-target=#top href=# id=nav-toggle><i class=kube-menu></i></a></div></div><div class=hide-sm id=top><div id=top-brand><a href=/ title=home>OpenADMET</a></div><nav id=top-nav-main><ul><li><a href=/jobs/>Jobs</a></li><li><a href=/members/>Members</a></li><li><a href=/datasets/>Datasets</a></li><li><a href=/news/>News</a></li><li><a href=/publications/>Publications</a></li><li><a href=/blog/>Blog</a></li></ul></nav><nav id=top-nav-extra><ul></ul></nav></div></header><main><div id=main><div id=hero><h1>OpenADMET Consortium</h1><p>Next generation ADMET modelling for therapeutic development</p></div><div id=main class=center><p>Small molecule therapies represent a significant portion of FDA-approved drugs, yet their development is often hindered by the challenge of balancing on-target activity with desirable pharmacokinetic (PK) properties.</p><p>Pharmacokinetic properties, which encompass absorption, distribution, metabolism, and excretion (ADME), determine a drug&rsquo;s fate within the body and are crucial for its efficacy and safety. Currently, the optimization of these properties is often addressed late in the drug discovery process, leading to costly late-stage failures.</p><p>The OpenADMET project seeks to overcome this limitation by proactively characterizing the chemical space accessible to ADMET-associated proteins (&ldquo;anti-targets&rdquo;). By applying recent advances in experimental and computational techniques, a comprehensive open library of experimental and structural datasets will be generated.</p><p>The precompetitive resources developed by OpenADMET will provide valuable insights into the binding properties of &ldquo;anti-targets&rdquo; and empower researchers to develop predictive AI models for pharmacokinetic optimization. This shift towards a more proactive and data-driven approach promises to significantly expedite drug discovery by streamlining lead optimization, mitigating late-stage attrition, and ultimately accelerating the delivery of new therapies to patients.</p><p>OpenADMET is funded through an ARPA-H grant: &ldquo;AVOID-OME: Structurally enabling the “avoid-ome” to accelerate drug discovery&rdquo;. Read more on the AVOID-OME concept <a href=http://cdn.fraserlab.com/publications/2024_fraser.pdf>here</a> and why we think turning the tools of modern drug discovery on the AVOID-OME can create meaningfull progress in drug discovery.</p></div><div><center><figure><img alt="Structural proteins in the AVOID-OME" src=/avoidome_dmpk_structures_hu17702482097529874257.png></figure></center></div><div id=hero><hr><h4>If you would like to get involved contact us <a href=mailto:saumya.krishnan@ucsf.edu>here</a></h4><h4><a href=https://pelosi.house.gov/news/press-releases/pelosi-announces-305-million-ucsf-research-drug-side-effect-prevention>Congressional Support for OpenADMET</a></h4><h4>An <a href=https://arpa-h.gov/>ARPA-H funded project (Grant Number: 1AY1AX000035-01)</a></h4></div></div></main><footer><footer id=footer><nav><ul><li><span>OpenADMET</span></li></li></ul></nav><p>&copy; Licence MIT.</p></footer></footer><script src=/js/kube.js type=text/javascript></script><script src=/js/kube.legenda.js type=text/javascript></script><script src=/js/main.js type=text/javascript></script></body></html>